ZA9510995B - Bone mass anabolic composition - Google Patents

Bone mass anabolic composition

Info

Publication number: ZA9510995B
Authority: ZA; South Africa
Prior art keywords: bone mass; anabolic composition; anabolic; composition; bone
Prior art date: 1994-12-28

Application number

ZA9510995A

Other languages

English (en)

Inventor

Socrates Papapoulos

Jose Luis Ferretti

Rafael Labriola

Nelida Mondelo

Emilio J A Roldan

Original Assignee

Gador Sa

Univ Leiden

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1994-12-28

Filing date

1995-12-28

Publication date

1997-06-30

1995-12-28 Application filed by Gador Sa, Univ Leiden filed Critical Gador Sa

1997-06-30 Publication of ZA9510995B publication Critical patent/ZA9510995B/xx

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/66—Phosphorus compounds
- A61K31/662—Phosphorus acids or esters thereof having P—C bonds, e.g. foscarnet, trichlorfon
- A61K31/663—Compounds having two or more phosphorus acid groups or esters thereof, e.g. clodronic acid, pamidronic acid
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/02—Nutrients, e.g. vitamins, minerals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

Health & Medical Sciences (AREA)
General Health & Medical Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Chemical & Material Sciences (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Medicinal Chemistry (AREA)
Animal Behavior & Ethology (AREA)
Life Sciences & Earth Sciences (AREA)
General Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Chemical Kinetics & Catalysis (AREA)
Physical Education & Sports Medicine (AREA)
Rheumatology (AREA)
Orthopedic Medicine & Surgery (AREA)
Hematology (AREA)
Obesity (AREA)
Epidemiology (AREA)
Immunology (AREA)
Diabetes (AREA)
Nutrition Science (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

ZA9510995A 1994-12-28 1995-12-28 Bone mass anabolic composition ZA9510995B (en)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
EP94120799		1994-12-28

Publications (1)

Publication Number	Publication Date
ZA9510995B true ZA9510995B (en)	1997-06-30

Family

ID=8216571

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
ZA9510995A ZA9510995B (en)	1994-12-28	1995-12-28	Bone mass anabolic composition

Country Status (11)

Country	Link
EP (1)	EP0800397B1 (es)
JP (1)	JP3796693B2 (es)
KR (1)	KR100385697B1 (es)
AR (1)	AR000555A1 (es)
AU (1)	AU701258B2 (es)
BR (1)	BR9510123A (es)
CA (1)	CA2208714C (es)
DE (1)	DE69534923T2 (es)
ES (1)	ES2262145T3 (es)
WO (1)	WO1996019998A1 (es)
ZA (1)	ZA9510995B (es)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
EP0753523A1 (en) *	1995-07-10	1997-01-15	Gador S.A.	Amino-substituted bisphosphonic acids
DE19719680A1 (de)	1997-05-09	1998-11-19	Boehringer Mannheim Gmbh	Verwendung von Diphosphonsäuren zur präventiven Behandlung von Spätfolgen bei Harnblasenerweiterung oder Harnblasenersatz
ES2231919T3 (es) *	1997-07-15	2005-05-16	Gador S.A.	Forma cristalina de sal monosodica monohidrato del acido n,n-dimetil-3-amino-1-hidroxipropano-1,1-difosfonico.
AR013994A1 (es) *	1998-10-30	2001-01-31	Gador Sa	Procedimiento y preparaciones que modulan selectivamente la funcion del osteoblasto para la prevencion y tratamiento de las osteopatias fragilizantes.
US6416737B1 (en) *	1998-11-19	2002-07-09	Board Of Trustees Of The University Of Arkansas	Increasing bone strength with selected bisphosphonates
WO2002058708A1 (en)	2001-01-23	2002-08-01	Gador S.A.	Composition comprising bisphosphonates for prevention and/or treatment of metabolic diseases of bones, process for preparing such composition and use thereof
RU2387451C2 (ru)	2002-05-10	2010-04-27	Ф.Хоффманн-Ля Рош Аг	Бисфосфоновые кислоты, предназначенные для лечения и профилактики остеопороза
WO2008157050A1 (en) *	2007-06-19	2008-12-24	Albemarle Corporation	Processes for manufacturing bisphosphonic acids

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
EP0381296B1 (en) *	1984-04-30	1994-11-30	THE PROCTER & GAMBLE COMPANY	Kit for use in the treatment of osteoporosis
RU2113848C1 (ru) *	1991-02-26	1998-06-27	Норвич Итон Фармасьютикалз, Инк.	Способ лечения остеопороза, композиция для лечения остеопороза, применение активно действующего на кости фосфоната и эстрогенного гормона для лечения остеопороза
NZ246456A (en) *	1991-12-17	1997-03-24	Procter & Gamble Pharma	Use of bone active phosphonate and a parathyroid hormone to prepare medicaments for a thirty day treatment regimen for osteoporosis
ATE161423T1 (de) *	1992-06-30	1998-01-15	Procter & Gamble Pharma	Verwendung von phosphinate zur behandlung der osteoporose
EP0600834A1 (en) *	1992-11-30	1994-06-08	Ciba-Geigy Ag	Use of methanebisphosphonic acid derivatives for the manufacture of a medicament for fracture healing
US5366965A (en) *	1993-01-29	1994-11-22	Boehringer Mannheim Gmbh	Regimen for treatment or prophylaxis of osteoporosis

1995
- 1995-12-27 EP EP95943216A patent/EP0800397B1/en not_active Expired - Lifetime
- 1995-12-27 AR AR33481795A patent/AR000555A1/es unknown
- 1995-12-27 AU AU44347/96A patent/AU701258B2/en not_active Expired
- 1995-12-27 CA CA002208714A patent/CA2208714C/en not_active Expired - Lifetime
- 1995-12-27 ES ES95943216T patent/ES2262145T3/es not_active Expired - Lifetime
- 1995-12-27 BR BR9510123A patent/BR9510123A/pt not_active Application Discontinuation
- 1995-12-27 KR KR1019970704467A patent/KR100385697B1/ko not_active Expired - Lifetime
- 1995-12-27 WO PCT/EP1995/005142 patent/WO1996019998A1/en not_active Ceased
- 1995-12-27 DE DE69534923T patent/DE69534923T2/de not_active Expired - Lifetime
- 1995-12-27 JP JP52021596A patent/JP3796693B2/ja not_active Expired - Lifetime
- 1995-12-28 ZA ZA9510995A patent/ZA9510995B/xx unknown

Also Published As

Publication number	Publication date
KR100385697B1 (ko)	2003-08-21
ES2262145T3 (es)	2006-11-16
AU701258B2 (en)	1999-01-21
DE69534923D1 (de)	2006-05-18
JP3796693B2 (ja)	2006-07-12
AR000555A1 (es)	1997-07-10
EP0800397A1 (en)	1997-10-15
BR9510123A (pt)	1997-12-30
WO1996019998A1 (en)	1996-07-04
CA2208714A1 (en)	1996-07-04
EP0800397B1 (en)	2006-04-05
AU4434796A (en)	1996-07-19
DE69534923T2 (de)	2006-11-23
CA2208714C (en)	2003-10-21
JPH11502506A (ja)	1999-03-02

Publication	Publication Date	Title
ZA951012B (en)	1996-08-08	Composition
ZA957233B (en)	1996-05-07	Topically-effective compositions
EG20929A (en)	2000-06-28	Cleasing compositions
GB9408545D0 (en)	1994-06-22	Compositions
HUT78017A (hu)	1999-05-28	Fogápoló készítmény
GB9425941D0 (en)	1995-02-22	Oral composition
GB9401787D0 (en)	1994-03-23	Vaccine compositions
GB9415810D0 (en)	1994-09-28	Composition
GB9409543D0 (en)	1994-06-29	Compositions
GB9502770D0 (en)	1995-03-29	Amine-curable compositions
ZA9510995B (en)	1997-06-30	Bone mass anabolic composition
GB2290299B (en)	1998-01-14	Anti-lubricant compositions
GB9416768D0 (en)	1994-10-12	Compositions
EP0705632A3 (en)	1996-10-23	Polyisobutylene-polydimethyl siloxane compositions terminated with a 2-methylpropenyl
GB9410139D0 (en)	1994-07-06	Hebicidal composition
GB9416767D0 (en)	1994-10-12	Compositions
GB9420354D0 (en)	1994-11-23	Composition
PL304514A1 (en)	1996-02-05	Resin-asphalt composition
GB9408548D0 (en)	1994-06-29	Composition
GB9417808D0 (en)	1994-10-26	Composition
GB9412943D0 (en)	1994-08-17	Composition
GB9407734D0 (en)	1994-06-15	Composition
HU9401077D0 (en)	1994-07-28	David-star composition
GB9405023D0 (en)	1994-04-27	Composition
GB9403417D0 (en)	1994-04-13	Vaccine compositions